Strategic Asset Management’s Medtronic MDT Stock Holding History

Strategic Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1K	Buy	+18	New	+$1.62K	﹤0.01%	558

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Strategic Asset Management's MDT Position: Q3 2022 in Review

Strategic Asset Management opened a new position in Medtronic (MDT) in Q3 2022: 18 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #558 among its holdings.

1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

Strategic Asset Management held 18 shares of Medtronic worth $1K as of Q3 2022.
Medtronic was a new Strategic Asset Management position in Q3 2022.
Medtronic made up ﹤0.01% of Strategic Asset Management's portfolio in Q3 2022, its #558 holding.
1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.